BioCentury
ARTICLE | Company News

J&J unit ends diabetes deal with Arena

November 5, 2010 12:26 AM UTC

Johnson & Johnson (NYSE:JNJ) unit Ortho-McNeil-Janssen Pharmaceuticals Inc. will terminate a 2004 deal and return rights to diabetes candidate APD597 to Arena Pharmaceuticals Inc. (NASDAQ:ARNA). The g...